Department of Medicine, Endocrinology Division, Overton Brooks VA Medical Center, Shreveport, LA 71101, USA.
J Intensive Care Med. 2013 Jan-Feb;28(1):37-45. doi: 10.1177/0885066611403994. Epub 2011 May 16.
Hypernatremia, defined as plasma sodium concentration >145 mEq/L, is frequently encountered in critically ill patients admitted to the intensive care unit (ICU). Hypernatremia indicates a decrease in total body water relative to sodium and is invariably associated with plasma hyperosmolality though total body sodium content may be normal, decreased, or increased. Hypernatremia usually occurs as a result of impaired thirst or access to water, with or without increased water losses from renal and extrarenal sources. Critically ill patients in ICU are at high risk of hypernatremia because of their inability to control free water intake as a result of sedation, intubation, change in mental status, and fluid restriction for various other reasons. In addition, excessive fluid losses from various renal or nonrenal sources and treatment with sodium containing fluids are commonly encountered in this population, predisposing them to hypernatremia. The consequences of hypernatremia result from osmotic movement of water across the cell membrane, leading to primarily intracellular and variable degree of extracellular volume depletion. The clinical features depend on severity and rapidity of hypernatremia development with abnormal cognitive and neuromuscular function in many cases and potential risk of hemorrhagic complications or death from vascular stretching and rupture in advanced cases. The management of hypernatremia focuses on judicious replacement of free water deficit to restore normal plasma osmolality as well as identification and correction of underlying causes of hypernatremia. Electrolyte-free water replacement is the preferred therapy though electrolyte (sodium) containing hypotonic fluids can also be used in some circumstances. Oral free water replacement guided by thirst is ideal though parenteral fluid replacement is usually necessary in critically ill ICU patients. Various calculations for estimating free water deficit are available and any can be used to guide initial fluid replacement therapy. Rate of correction depends on rapidity of hypernatremia development, though frequent monitoring of plasma sodium levels is essential to ensure appropriate response and to adjust the rate of fluid replacement to prevent the risk of cerebral edema from rapid correction of chronic hypernatremia. Free water requirements should be routinely assessed in ICU patients and judicious electrolyte and free water replacement prescribed for those at risk of hypernatremia.
高钠血症定义为血浆钠浓度>145mEq/L,常发生于入住重症监护病房(ICU)的危重症患者。高钠血症表示相对于钠,总身体水减少,尽管总身体钠含量可能正常、减少或增加,高钠血症始终与血浆高渗透压相关。高钠血症通常是由于口渴或水摄入受损引起,可能伴有肾和肾外来源的水丢失增加。由于镇静、插管、精神状态改变和各种其他原因的液体限制,ICU 中的危重症患者无法控制自由水摄入,因而处于高钠血症的高风险中。此外,由于各种肾或非肾来源的液体过度丢失以及使用含钠液体治疗,该人群易发生高钠血症。高钠血症的后果是由于水分子穿过细胞膜的渗透运动,导致主要是细胞内和可变程度的细胞外体积耗竭。临床特征取决于高钠血症发展的严重程度和速度,在许多情况下,会出现异常认知和神经肌肉功能,在晚期情况下,由于血管拉伸和破裂,存在出血并发症或死亡的潜在风险。高钠血症的管理重点是明智地补充自由水不足,以恢复正常的血浆渗透压,以及识别和纠正高钠血症的根本原因。无电解质水补充是首选治疗方法,尽管在某些情况下也可以使用含电解质(钠)的低渗液。根据口渴指导口服补充自由水是理想的,但在危重症 ICU 患者中通常需要静脉补液。有多种计算方法可用于估计自由水不足,任何一种方法都可用于指导初始液体补充治疗。纠正速度取决于高钠血症发展的速度,尽管频繁监测血浆钠水平对于确保适当的反应和调整液体补充速度以防止从慢性高钠血症快速纠正中出现脑水肿风险至关重要。应常规评估 ICU 患者的自由水需求,并为有高钠血症风险的患者合理补充电解质和自由水。